ŽRθ@Ή”ό

‘ε“€‚½‚ρ”’ŽΏƒΐ-ƒRƒ“ƒOƒŠƒVƒjƒ“‚Μ”ρƒAƒ‹ƒR[ƒ‹«Ž‰–bŠΜ‰ό‘PENASH—\–hŒψ‰Κ‚ƍμ—p‹@˜‚Μ‰π–Ύ
The Effect of Soy Protein ƒΐ-conglycinin on Nonalcoholic Fatty Liver Disease and NASH
ŽRθ@Ή”ό y‘ζ35 Šͺ2014 Page99z
‘ε“€‚½‚ρ”’ŽΏβ- ƒRƒ“ƒOƒŠƒVƒjƒ“‚Μ”ρƒAƒ‹ƒR[ƒ‹«Ž‰–bŠΜ”­Η—\–hEŽ‘—ΓŒψ‰Κ‚ƍμ—p‹@˜‚Μ‰π–Ύ
Effect of Soy Protein β-Conglycinin on Nonalcoholic Fatty Liver Disease
ŽR핁@Ή”ό y‘ζ32 Šͺ2011 Page86z
‘ε“€‚½‚ρ”’ŽΏβ - ƒRƒ“ƒOƒŠƒVƒjƒ“‚Μ”ρƒAƒ‹ƒR[ƒ‹«Ž‰–bŠΜ”­Η—\–h‚¨‚ζ‚Ρ
Ž‘—ΓŒψ‰Κ‚ƍμ—p‹@˜‚Μ‰π–Ύ
Effect of Soy Protein β-Conglycinin on Nonalcoholic Fatty Liver Disease
ŽRθ@Ή”ό y‘ζ31 Šͺ2010 Page128z
‘ε“€‚½‚ρ”’ŽΏƒΐ-ƒRƒ“ƒOƒŠƒVƒjƒ“‚Μ”ρƒAƒ‹ƒR[ƒ‹«Ž‰–bŠΜ”­Η‚Ι‘Ξ‚·‚ιŒψ‰Κ‚ƍμ—p‹@˜‚Μ‰π–Ύ
Effect of Soy Bean ƒΐ-conglycinin on Nonalcoholic Fatty Liver Disease
ŽRθ@Ή”όy‘ζ30 Šͺ2009 Page158z